Assessment of Asymptomatic Heart Disease in Children With HIV
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20130305102345im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
The purpose of this study is to perform cardiac evaluation in HIV-1 (predominantly clade C)infected children by history, physical examination, echocardiogram and plasma N-terminal pro-B-type natriuretic peptide (N-BNP)measurement in order to determine asymptomatic abnormalities.
Condition | Intervention |
---|---|
HIV Infections |
Procedure: echocardiography and blood test |
Study Type: | Interventional |
Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
Official Title: | Evaluation of the Cardiac Complications in Congenitally HIV-1 Infected Children in Israel by the Echocardiography and Measurement of N-Terminal Pro-B-Type Natriuretic Peptide (N-BNP). |
Study Start Date: | January 2007 |
Human immunodeficiency virus (HIV) infection affects nearly 40 million adults and children worldwide. Recently introduced new antiviral drugs have significantly improved survival of patients with HIV infection. As mortality declines, morbidity becomes a concern. Heart disease is present in 20% of children and adults with HIV. The cardiac diseases include left ventricular dysfunction, hypertrophy and dilation, pericardial effusion and intracardiac masses. Cardiac disease is an independent risk factor for death in these children. The reported two-year survival of children with congestive heart failure is zero compared to 17% when no heart failure is present. It is thus indicated to perform periodic cardiac examinations in these patients, and early recognition of cardiac disease is paramount.
In addition to the traditional tools to assess cardiac status which include history, physical examination, ECG, chest X-ray and echocardiography, we propose to check biochemical markers. Brain natriuretic peptide has been shown to be a very sensitive marker for symptomatic and asymptomatic cardiac dysfunction, prognosis, severity of the disease and response to therapy in adults. Troponin-T is a very good marker for cardiac ischemia. Recently, we have found troponin-T to be a good marker for acute cardiac insult in infants and children.
The aim of this study is to perform screening of children with HIV predominantly clade C for cardiac disease using the above mentioned means.
![](https://webarchive.library.unt.edu/web/20130305102345im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Infants and children congenitally infected with HIV-1
![](https://webarchive.library.unt.edu/web/20130305102345im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Contact: Diana Averbuch, MD | 972-50-7874940 | dina8282@walla.co.il |
Contact: Hadas Lemberg, PhD | 00 972 2 6777572 | lhadas@hadassah.org.il |
Israel | |
Hadassah University Hospital, Pediatric Department, Pediatric AIDS Center | Recruiting |
Jerusalem, Israel, 91120 | |
Contact: Diana Averbuch, MD 972-50-7874940 dina8282@walla.co.il | |
Contact: Dan Engelhard, MD 972-2-6778960 engelhard@hadassah.org.il | |
Principal Investigator: Diana Averbuch, MD | |
Principal Investigator: Dan Engelhard, MD | |
Sub-Investigator: Amiram Nir, MD | |
Sub-Investigator: Azaria Rein, MD |
Principal Investigator: | Diana Averbuch, MD | Hadassah University Hospital, Jerusalem, Israel |
![](https://webarchive.library.unt.edu/web/20130305102345im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Publications:
ClinicalTrials.gov Identifier: | NCT00426374 History of Changes |
Other Study ID Numbers: | yael11-HMO-CTIL |
Study First Received: | January 23, 2007 |
Last Updated: | January 31, 2007 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Keywords provided by Hadassah Medical Organization:
HIV AIDS Troponin natriuretic peptide |
heart failure heart disease children HIV pediatric AIDS pediatric |
Additional relevant MeSH terms:
HIV Infections Acquired Immunodeficiency Syndrome Heart Diseases Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes |
Immune System Diseases Slow Virus Diseases Cardiovascular Diseases Natriuretic Peptide, Brain Natriuretic Agents Physiological Effects of Drugs Pharmacologic Actions Cardiovascular Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on March 03, 2013